MLANA and melanoma: An oncolytic adenovirus expressing a TGF-β2 shRNA and granulocyte-macrophage colony stimulating factor (GM-CSF) can significantly enhance the anti-melanoma efficacy of melanoma antigen Melan-A (MART1) in mice (14).